Mary Beth Nierengarten

Reducing Risk of Stroke in Patients with TIA

10/23/2013

A recent trial shows that combining clopidogrel and aspirin is superior to aspirin alone for reducing the risk of stroke among patients with TIA.

A recent trial shows that...

10/23/2013

First Report Managed Care

Increased Risk of Falls, Fractures and Narcotics

03/16/2012

Mary Beth Nierengarten ;

Chicago—Current guidelines that recommend short-term narcotic analgesics (NAs) as first-line treatment for managing chronic pain may need to be reevaluated based on new data that show an increased risk of falls and fractures in elderly...

Chicago—Current guidelines that...

03/16/2012

First Report Managed Care

Conference Insider

Accountable Care Organizations: Role of Pharmacists

11/20/2013

Mary Beth Nierengarten ;

San Antonio—Since 2010, the number of Accountable Care Organizations (ACOs) has grown in the United States, with many states now moving toward adopting this new model of healthcare delivery. Currently, most of the ACOs involve public programs...

San Antonio—Since 2010, the...

11/20/2013

First Report Managed Care

Feature

Preparing for Emergencies: Communication, Funding, and Innovation

04/18/2022

Mary Beth Nierengarten ;

With hospitals and health care systems already under constant pressure to be adequately prepared for natural disasters and other emergencies, refining risk assessments and a network of partners with clear communication actively in place has...

With hospitals and health care...

04/18/2022

First Report Managed Care

Washington Comes Together to Tackle Opioids

11/16/2018

Mary Beth Nierengarten ;

A group of experts recently commented on President Trump's new law addressing the opioid crisis that received strong bipartisan support, which provides multiple measures to more aggressively address what has become a steady and growing...

A group of experts recently...

11/16/2018

First Report Managed Care

Addition of Ovarian Suppression to Tamoxifen in Select Early Breast Cancer Patients

02/17/2015

Mary Beth Nierengarten ;

A study found that adding ovarian suppression to tamoxifen improved disease outcomes in specific populations of premenopausal women with hormone receptor-positive early breast cancer.

A study found that adding...

02/17/2015

First Report Managed Care

Biologic Agents and Mortality Risk in Rheumatoid Arthritis

02/14/2013

Mary Beth Nierengarten ;

Washington, DC—Treatment of rheumatoid arthritis (RA) with biologic agents is associated with a significant reduction in mortality, Canadian researchers reported in a population-based cohort study presented at the ACR meeting. Although the...

Washington, DC—Treatment of...

02/14/2013

First Report Managed Care

Feature

Treating Psoriasis with Biologic Agents

05/05/2010

Mary Beth Nierengarten ;

Miami Beach—According to a consensus statement by the American Academy of Dermatology (AAD), biologic agents may be considered among the options for first-line treatment, along with systemic therapies or phototherapy, for patients with...

Miami Beach—According to a...

05/05/2010

First Report Managed Care

News Connection

Patients with Gout Treated with Febuxostat Compared with Those Treated with Allopurinol

02/09/2012

Mary Beth Nierengarten ;

Patients with gout treated with febuxostat have more comorbidities and higher mean baseline serum uric acid levels compared with patients treated with allopurinol.

Patients with gout treated with...

02/09/2012

First Report Managed Care

News

Employing Managed Care to Avert a Diabetes Epidemic

01/23/2017

Mary Beth Nierengarten ;

Diabetes and pre-diabetes represent a growing threat to the health of the American public and the future of the health care system at-large.

Diabetes and pre-diabetes...

01/23/2017

First Report Managed Care